Simple blood draw. Diagnosis of vascular risk. Smart living.
Identify potential arterial injury due to inflammation.
SmartVascular Dx Test Benefits
Measures
- 7 protein biomarkers to identify arterial injury
- CTACK, Eotaxin, Fas Ligand, HGF, IL-16, MCP-3
- and sFas
Determines
- Endothelial Inflammation
- Identifies soft liaison risk undetected today by
- other blood tests or stroke
SmartVascular Dx Collection Network
We utilize My One Medical Source® (MOMS) to access a nationwide network of MAPs: Medical Access Point/Providers™. MOMS helps to connect you with conveniently located medical MAPs.
About SmartVascular Dx
SmartVascular Dx has been developed through a series of longitudinal outcome-based studies with multiple institutions over a 15-year period of collaborative research representing over 40,000 patients. Our test has been independently validated at the National Institute of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) in the Multi-Ethnic Study of Atherosclerosis (MESA).
Advantages
- Clear and accurate reporting of current overall health status from endothelial damage caused by inflammation.
- Easy-to-read physician report showing results at a glance with current health and serial reporting for multi-year tracking.
- Ability to request the test annually to stay on track with health monitoring.
- Independent validation with multiple patient ethnicities.